Takeda Pharmaceutical Co Ltd president Giles Richard Platford sells $1.16M of stock; filing shows no 10b5-1 plan
The sale reduces the insider's holding by 17%, the filing shows.
Giles Richard Platford sold about $1.2 million of Takeda Pharmaceutical Co Ltd (TAK) stock on Nov 4, according to an SEC filing. The president received an average of $20.90 for 55,617 shares.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The sale reduces the insider's holding by 17%, to 270,253 shares.
The trade was reported within two business days, as Section 16 requires.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Takeda Pharmaceutical Co Ltd (TAK) |
|---|---|
| Insider | Giles Richard Platford |
| Role | President |
| Transaction | Open-market sale (code S) |
| Shares | 55,617 |
| Average price | $20.90 |
| Value | $1,162,395 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 5, 2026, 3:54 PM ET |
| Shares held after | 270,253 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
Browse the latest insider selling · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
